Heartland Bridge to invest in HepatoChem - MarketLine Financial Deals

Heartland Bridge to invest in HepatoChem

Heartland Bridge to invest in HepatoChem - MarketLine Financial Deals
Heartland Bridge to invest in HepatoChem
Published Jul 26, 2011
2 pages — Published Jul 26, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Heartland Bridge Capital, Inc., a holding and investment company, has signed an agreement to invest in HepatoChem, Inc.

  
Source:
Document ID
MA72808_110727
Country
Ticker
HLBC=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Heartland Bridge to invest in HepatoChem" Jul 26, 2011. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Heartland-Bridge-to-invest-in-HepatoChem-2052-65105>
  
APA:
MarketLine Financial Deals. (2011). Heartland Bridge to invest in HepatoChem Jul 26, 2011. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Heartland-Bridge-to-invest-in-HepatoChem-2052-65105>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.